LIN28A and neurodevelopmental disorder: LIN28A is emerging as a key oncogene and biomarker for multiple cancers (Jiang and Baltimore, 2016; Li et al., 2012), and its dysregulation has also been implicated in diseases such as diabetes (Thornton and Gregory, 2012) and neurodevelopmental disorders (Kim et al., 2019).